- Home
- SRPT vs JLS Comparison
SRPT vs JLS Comparison
Compare SRPT & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- JLS
- Stock Information
- Founded
- SRPT 1980
- JLS 2009
- Country
- SRPT United States
- JLS United States
- Employees
- SRPT N/A
- JLS N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- JLS Investment Managers
- Sector
- SRPT Health Care
- JLS Finance
- Exchange
- SRPT Nasdaq
- JLS Nasdaq
- Market Cap
- SRPT N/A
- JLS 97.1M
- IPO Year
- SRPT 1997
- JLS N/A
- Fundamental
- Price
- SRPT $17.20
- JLS $18.74
- Analyst Decision
- SRPT Buy
- JLS
- Analyst Count
- SRPT 25
- JLS 0
- Target Price
- SRPT $64.00
- JLS N/A
- AVG Volume (30 Days)
- SRPT 7.5M
- JLS 26.6K
- Earning Date
- SRPT 08-06-2025
- JLS 01-01-0001
- Dividend Yield
- SRPT N/A
- JLS 9.33%
- EPS Growth
- SRPT N/A
- JLS N/A
- EPS
- SRPT N/A
- JLS N/A
- Revenue
- SRPT $2,233,371,000.00
- JLS N/A
- Revenue This Year
- SRPT $26.87
- JLS N/A
- Revenue Next Year
- SRPT $3.15
- JLS N/A
- P/E Ratio
- SRPT N/A
- JLS N/A
- Revenue Growth
- SRPT 59.15
- JLS N/A
- 52 Week Low
- SRPT $16.96
- JLS $15.48
- 52 Week High
- SRPT $162.95
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- SRPT 18.61
- JLS 63.16
- Support Level
- SRPT $18.30
- JLS $18.21
- Resistance Level
- SRPT $22.98
- JLS $18.54
- Average True Range (ATR)
- SRPT 1.98
- JLS 0.18
- MACD
- SRPT -1.19
- JLS 0.02
- Stochastic Oscillator
- SRPT 0.89
- JLS 75.94
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.